Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Clinical trials have shown that tirzepatide can lead to significant weight loss, with participants losing between 15% to 20% of their initial body weight over time
Cagrilintide vs tirzepatide (Mounjaro/Zepbound) Mechanism: Cagrilintide: Amylin agonist Tirzepatide: Dual GIP/GLP-1 agonist Both novel approaches Weight loss: Cagrilintide: 10-12% monotherapy Tirzepatide: 15-22% monotherapy Tirzepatide superior as single agent Administration: Both: Weekly subcutaneous injection Both: Similar convenience Side effects: Cagrilintide: Strong GI effects Tirzepatide: Moderate GI effects Similar overall profile Approval status: Cagrilintide: Investigational Tirzepatide: FDA approved Tirzepatide available now Cost (when both available): Likely similar ($1,000-1,500/month) Both premium weight loss options Verdict: Currently, tirzepatide better choice (approved, superior weight loss)
Inflammation tirzepatide has been shown to reduce systemic inflammation (ScienceDirect, 2024) Taken together, these benefits show that tirzepatide is more than a weight-loss medicationit also helps protect your metabolism, heart, liver, kidneys, and sleep health
Among those who stopped, 24% cited side effects and 28% said they had reached their target weight
